Coverage analysis built for speed, intelligence, and audit-ready accuracy.
Manual coverage analysis is fragmented, slow, and hard to audit. Ginseng changes that.
Under 30 minutes per coverage analysis — versus 15-50 days at benchmarked cancer centers.
At least 30% lower cost than outsourced coverage analysis - more at scale.
Ginseng strives for 90% accuracy on oncology coverage analyses, grounded in NCCN guidelines, NCDs/LCDs, FDA drug labels, eviCore imaging guidelines, and Children's Oncology Group (COG) guidelines, tailored to institutional risk tolerance.
Speed isn't just about turnaround time - it's bandwidth. Ginseng gives research teams room to do compliance right, not just on time.
*Conditional savings depend on volume, contract duration, and program specifics.
Our engine cross-references NCCN, NCDs, LCDs, and FDA labels against your protocol, building a transparent, audit-ready coverage determination for every trial.
Reduce manual effort and improve accuracy.
Shorten review time and accelerate decisions.
Streamline communication and keep everyone aligned.
Collect, track, and resolve feedback in one place.
Built for regulated environments and audit readiness.
Monitor progress and stay ahead of deadlines.
Ginseng is a proprietary intelligent SaaS solution for coverage analysis for clinical trials. Built with a Physician-Developed Clinical & Regulatory Engine, a Coverage Analysts Validated Algorithm, and Selective AI Application that requires limited human review.
PonteOpen gives sponsors, hospitals, laboratories, and providers a unified view of timelines, tasks, updates, and project progress — all in one place.
Insights from our pilot programs at the forefront of oncology research. Ginseng generated complex coverage analyses, including successful basket and multi-arm studies, with no functional blockers during testing.
“I would happily do this [Ginseng CA Process] 20 times rather than spend hours on the same CA in our current system [process].”
“I could complete an MCA and a budget in the same day with this [Ginseng].”
“It was nice to see... the heavier-hitting studies [multiple solid tumor studies with 30+ cancer types] come through the [Ginseng] system.”
“This [Ginseng] looks much more implementable [compared to other systems]. Once we have the institutional specifics [guidelines and risk tolerance] configured [in Ginseng], we'll have a really impactful product for CA.”
“[Even] having the [CA] shell — 60–70% done — reduces the manual build work significantly [100x faster].”
“This [Ginseng] is very innovative and sleek. I can see this spreading across the field [All Therapeutic Areas (TAs) and cancer centers].”
“It [CA billing grid output] looks just like our template. That's amazing.”
“Uploading and putting the information in [Ginseng] is easy. Getting it to the review point and editing [in Ginseng] is nothing.”
“...an initial internal budget template off the coverage analysis output, that puts us ten days ahead of where we were!”
At NAUR, we identify and close measurable gaps in healthcare and life sciences through advanced software solutions. Our mission is to help organizations work with greater clarity, efficiency, and impact.
